Incyte Corp (NASDAQ:INCY)

Monday’s Biggest Winners and Losers in the S&P 500

June 5, 2017: The S&P 500 closed slightly lower on the day, at 2,436.18. Separately the DJIA closed down 0.1% at 21,184.45. The Nasdaq also closed down 0.16% at 6,295.68. ...
Read Full Story »

7 ASCO Stocks Moving on Cancer Study News (Updated)

Note: Share prices have been updated. The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on ...
Read Full Story »

15 Companies Bracing for Big ASCO Reactions

This year marks the 53rd Annual Meeting for the American Society of Clinical Oncology (ASCO), where biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference (June ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

May 18, 2017: The S&P 500 closed higher on the day, up 0.4% at 2,365.74. Separately the DJIA closed up 0.3% as well at 20,662.67. The Nasdaq closed up 0.7% ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Ambac, Bed Bath & Beyond, GE, Tiffany, Trade Desk and Many More

Stocks were indicated to open marginally lower on Friday after the equity indexes posted a mixed week. It still needs to be considered that the major market indexes are all ...
Read Full Story »

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Stocks were indicated up about 0.1% in Dow and S&P futures on Monday, with light market participation from some European markets after Easter. The bull market may be more than ...
Read Full Story »

Analysts See 10 Companies Beating Expectations This Earnings Season

With earnings starting to really snowball next week, and a market that seems to be teetering somewhat due to high valuations and some messy geopolitical issues, it makes sense for ...
Read Full Story »

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

If any industry has been under pressure over the past year or so, it has been biotechnology. While there are some positives for the industry, it still faces some definite ...
Read Full Story »

The 5 Best Performing S&P 500 Stocks for Q1

Between the November election and the end of 2016, the S&P 500 index gained 4.6%. Since the beginning of 2017, the index has added another 5.53%. The so-called Trump bump ...
Read Full Story »

Top-Performing S&P 500 Stocks Already Showing Gains of 30% to 50% in 2017

With eight days of selling in the broader stock market, a feat not recorded since 2011, many investors may be worried that the Trump-bump post-election rally might be over. Time will ...
Read Full Story »

What a Combined Gilead and Incyte Would Look Like

Gilead Sciences Inc. (NASDAQ: GILD) has long been in need of a catalyst to move its business, and a lot of investors and analysts alike have considered this company dead ...
Read Full Story »
Profit or Loss

Top 5 Earnings to Look For on Tuesday

The most recent earnings season is coming to a close, and the broad markets are pushing even higher with the Dow, Nasdaq and S&P 500 hitting new highs within the ...
Read Full Story »
Handshake

Why This Collaboration Is So Important for Calithera

Shares of Calithera Biosciences Inc. (NASDAQ: CALA) saw a solid gain early on Monday after the company reported a global collaboration and licensing agreement with Incyte Corp. (NASDAQ: INCY). Ultimately, this ...
Read Full Story »
Good heart health

Why Credit Suisse Sees Incyte Rising Over 15%

Incyte Corp. (NASDAQ: INCY) is one of the health care stocks that hit it big in 2016 — that is, after it crashed and burned. As we all know, 2016 ...
Read Full Story »